Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 805 results for "maa exchange"

Mid-America Apartment Communities (MAA) Hold Rating Reiterated at Jefferies Group
American Banking News - Forex

Metropolitan Life Insurance Co. NY Acquires 1,971 Shares of Mi...

Metropolitan Life Insurance Co. NY boosted its stake in shares of Mid-America Apartment Communities Inc. (NYSE:MAA) by 2.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned ... Zolmax News, 6 hours ago
MAA Reports Second Quarter Results ProfitQuotes.com, 1 day ago
[x]  

10 images for maa exchange

Security Intelligence, 2 months ago
Security Intelligence, 2 months ago
Security Intelligence, 2 months ago
NewsOK.com, 3 months ago
Chicago Daily Herald, 3 months ago
Daily Tribune, 3 months ago
Security Intelligence, 2 months ago
Pueblo Chieftain Online, 3 months ago
Mail.com, 3 months ago
Boston Herald, 3 months ago

SB5 , An Adalimumab Biosimilar Referencing Humira, Accepted For Review By European Medicines Agency

ZUG, Switzerland--( BUSINESS WIRE )--The Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira ®1 , has been accepted for review by the European Medicines Agency (EMA). The MAA for SB5 is the third ...
 BioSpace1 week ago SB5, An Adalimumab Biosimilar Referencing Humira®, Accepted for Review by European Medicines Agency  Pharmaceutical Tech.com1 week ago BIOGEN : SB5, An Adalimumab Biosimilar Referencing Humira®, Accepted for Review by European Medicines Agency  4 Traders1 week ago
[x]  
catchnews.com

Watch: Spiritual gurus wrestle on national Television over debate on Radhe Maa

Courtesy IBN7Shocking scenes were witnessed on national television when two guests on a live show used expletives, slapped and grappled with each other, leaving the audience aghast and prompting the channel to condemn the incident.A self-styled godman Om Ji ...
 catchnews.com2 months ago

GEM - Cancellation Notice

REPORT OF THE BOARD OF THE IRISH STOCK EXCHANGE CANCELLATION NOTICE Irish Stock Exchange 28 Anglesea Street Dublin 2 27th July 2016 Listing and trading of the under mentioned security has been cancelled with effect from 26th July 2016.
 MoneyAM1 day ago

Auto companies hope for stronger ringgit

PETALING JAYA: Local automotive players with foreign exchange (forex) exposure are hopeful that the ringgit will start to strengthen by next year. During a review of vehicle sales for the first half of 2016 by the Malaysian Automotive Association ...
 CarSifu3 days ago

DarioHealth is Now DirecttoConsumer in Australia

BOSTON , July 28, 2016 /PRNewswire/ -- DarioHealth Corp. (NASDAQ:DRIO), a leader in digital health and mobile health solutions and the developer of the Dario (T M ) Smart Diabetes Management Solution, today announced that it has begun offering ...
 Pharma Focus Asia4 minutes ago DarioHealth is Now Direct-to-Consumer in Australia  4 Traders16 hours ago LabStyle Innovations Now DarioHealth  Asian Hospital & Healthcare Management22 hours ago DarioHealth is Now Direct-​to-Consumer in Australia  Ariva.de16 hours ago
[x]  

Omeros Corporation Confirms OMS721 Phase 3 Development Plan with European Medicines Agency

/PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has received scientific advice from the European Medicines Agency (EMA) in connection with the company's OMS721 Phase 3 program for the treatment of atypical hemolytic uremic ...
 Barchart15 hours ago Omeros Confirms OMS721 Phase 3 Development Plan With EMA  BioSpace13 hours ago OMEROS CORPORATION : Confirms OMS721 Phase 3 Development Plan with European Medicines Agency  4 Traders15 hours ago
[x]  

GSI Technology, Inc. Reports Preliminary First-Quarter Fiscal 2017 Results

- GSI Technology, Inc. (NASDAQ: GSIT) today reported financial results for its first fiscal quarter ended June 30, 2016. The results that we are reporting today are preliminary, pending the completion of our review of confirmatory resale information ...
 Yahoo! Finance UK and Ireland8 hours ago
[x]  

Ultragenyx Announces Completion of Enrollment in Phase 3 Study of Aceneuramic Acid Extended Release (Ace-ER) in GNE Myopathy

(GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that it has completed patient enrollment in the Phase 3 ...
 Benzinga.com1 day ago ULTRAGENYX PHARMACEUTICAL : Announces Completion of Enrollment in Phase 3 Study of Aceneuramic Acid Extended Release (Ace-ER) in GNE Myopathy  4 Traders9 hours ago
[x]  

FDA Accepts BLA for BioMarin's Cerliponase Alfa for CLN2 Disease, Form of Batten Disease

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the submission of a Biologics License Application (BLA) for cerliponase alfa, an investigational therapy to treat ...
 Minyanville1 day ago BIOMARIN PHARMACEUTICAL : FDA Accepts BLA for BioMarins Cerliponase Alfa for CLN2 Disease, Form of Batten Disease  4 Traders9 hours ago FDA Accepts BLA for BioMarin 's Cerliponase Alfa for CLN2 Disease, Form of Batten Disease  Stockwatch1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less